Matthew Frohn is a co-founder and Partner at Longwall Venture Partners. See sector focus and contact routes.
Matthew Frohn is a co-founder and Partner at Longwall Venture Partners, an Oxford-based firm that invests $1 million to $5 million in early-stage deep tech companies, primarily at the pre-seed and seed levels. His investment focus centers on UK science and research in sectors including biotech, healthcare, medical devices, molecular diagnostics, and engineering, with a thesis to translate academic breakthroughs into commercially viable ventures addressing global challenges. Notable portfolio companies he has supported include OrganOx, Caristo Diagnostics, Lightcast Discovery, and Oxford PV. Frohn brings over 25 years of experience as a life science venture investor, having served as an investor, director, or chair for multiple healthcare and life science technology businesses.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Oxford when building a target list.
Investors like Matthew Frohn · Full investor directory · Investor access · Company funding database